REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer

BACKGROUND: Previous clinical trials have demonstrated the potential efficacy of rechallenge with anti- epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) for patients with RAS/BRAF V600E wild-type metastatic colorectal cancer (mCRC). Moreover, post hoc biomarker analyses of clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Hiromichi, Kotani, Daisuke, Bando, Hideaki, Kato, Takeshi, Oki, Eiji, Shinozaki, Eiji, Sunakawa, Yu, Yamazaki, Kentaro, Yuki, Satoshi, Nakamura, Yoshiaki, Yamanaka, Takeharu, Yoshino, Takayuki, Ohta, Takashi, Taniguchi, Hiroya, Kagawa, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186219/
https://www.ncbi.nlm.nih.gov/pubmed/34098908
http://dx.doi.org/10.1186/s12885-021-08395-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186219/
https://www.ncbi.nlm.nih.gov/pubmed/34098908
http://dx.doi.org/10.1186/s12885-021-08395-2

Ejemplares similares